TherOx Gets $30M For Heart Attack Treatment

Irvine-based TherOx, a developer of medical devices for treating heart attacks, said today that it has closed on $30M in venture funding. The funding round was led by DAG Ventures, and also included Kleiner Perkins Caufield & Byers, New Science Ventures, Integral Capital Partners, Aperture Venture Partners and Cross Creek Capital. TherOx is developing a device focused on Myocardial Salvage Intervention, a treatment performed on Acute Myocardial Infarction patients. More information »